X‑Chem and Structural Genomics Consortium Enter Into Collaboration to Unlock the Human Proteome and Promote Open Science
WALTHAM, Mass.; Sept. 28, 2023 (Business Wire) β X-Chem, a global leader in innovative drug discovery services, and the Structural...
The Power of DNA-Encoded Libraries for Covalent Inhibitor Discovery
Most of the pharmaceutical industryβs reported drug discovery projects involve reversible target modulators. However, covalent inhibitors β i.e., irreversible β...
Through the Lens of a Lead Discovery Scientist: Enabling Hit Identification Through DNA-Encoded Libraries
The phrase βyou miss 100% of the shots you donβt takeβ was originally coined by Wayne Gretzky about scoring goals...
X‑Chem Receives DEL Technology Grant
In 2019 X-Chem Zrt. (formerly ComInnex Zrt.) was awarded a grant (2019-1.1.1-PIACI-KFI-2019-00070) to first discover new DEL technologies in Hungary.
Karen Lackey
Karen brings over 30 years of international leadership in drug discovery and new technologies to the X-Chem team. Her experience...
X‑Chem Appoints Chief Scientific Officer and Chief Financial Officer
WALTHAM, Mass.; Aug. 10, 2023 (Business Wire) β X-Chem, the leading provider of innovative solutions in early-stage drug discovery, announced...
Alex Drijver
Alex is a business builder and strategic thinker, recognized with both an R&D 100 Award and the Hungarian Innovation Prize....
Kinases
X-Chemβs DEL TechnologyIs Changing How Kinase Discovery Is Done Kinase inhibitors have long been a target of drug discovery programs,...
X‑Chem Acquires ComInnex
Extending Functional and Global Leadership in Small Molecule Drug Discovery WALTHAM, Mass.; Oct. 25, 2021 β X-Chem, the pioneer of...